Positive Price to Sales

PPHI
 Stock
  

USD 8.75  0.00  0.00%   

Positive Physicians Holdings fundamentals help investors to digest information that contributes to Positive Physicians' financial success or failures. It also enables traders to predict the movement of Positive OTC Stock. The fundamental analysis module provides a way to measure Positive Physicians' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Positive Physicians otc stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Positive Price to Sales Analysis

Positive Physicians' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
P/S 
 = 
MV Per Share 
Revenue Per Share 
More About Price to Sales | All Equity Analysis

Current Positive Physicians Price to Sales

    
  1.42 X  
Most of Positive Physicians' fundamental indicators, such as Price to Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Positive Physicians Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition

Based on the latest financial disclosure, the price to sales indicator of Positive Physicians Holdings is roughly 1.42 times. This is 34.26% lower than that of the Financial Services sector and significantly higher than that of the Insurance—Specialty industry. The price to sales for all United States stocks is 87.57% higher than that of the company.

Positive Price to Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Positive Physicians' direct or indirect competition against its Price to Sales to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Positive Physicians could also be used in its relative valuation, which is a method of valuing Positive Physicians by comparing valuation metrics of similar companies.
Positive Physicians is currently under evaluation in price to sales category among related companies.

Positive Fundamentals

About Positive Physicians Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Positive Physicians Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Positive Physicians using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Positive Physicians Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Positive Physicians Holdings, Inc., through its subsidiary Positive Physicians Insurance Company, provides medical malpractice insurance. Positive Physicians Holdings, Inc. is a subsidiary of Insurance Capital Group, LLC. Positive Physicians operates under InsuranceSpecialty classification in the United States and is traded on OTC Exchange. It employs 23 people.

Positive Physicians Investors Sentiment

The influence of Positive Physicians' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Positive. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Positive Physicians in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Positive Physicians' short interest history, or implied volatility extrapolated from Positive Physicians options trading.

Currently Active Assets on Macroaxis

Please check Positive Physicians Piotroski F Score and Positive Physicians Altman Z Score analysis. Note that the Positive Physicians information on this page should be used as a complementary analysis to other Positive Physicians' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Positive OTC Stock analysis

When running Positive Physicians price analysis, check to measure Positive Physicians' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Positive Physicians is operating at the current time. Most of Positive Physicians' value examination focuses on studying past and present price action to predict the probability of Positive Physicians' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Positive Physicians' price. Additionally, you may evaluate how the addition of Positive Physicians to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Positive Physicians' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Positive Physicians. If investors know Positive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Positive Physicians listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
31.6 M
Quarterly Revenue Growth YOY
-0.009
Return On Assets
-0.0125
Return On Equity
-0.0351
The market value of Positive Physicians is measured differently than its book value, which is the value of Positive that is recorded on the company's balance sheet. Investors also form their own opinion of Positive Physicians' value that differs from its market value or its book value, called intrinsic value, which is Positive Physicians' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Positive Physicians' market value can be influenced by many factors that don't directly affect Positive Physicians' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Positive Physicians' value and its price as these two are different measures arrived at by different means. Investors typically determine Positive Physicians value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Positive Physicians' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.